NASDAQ:EKSO   Ekso Bionics Holdings, Inc
with the sale of common stock below its most recent highs, Ekso set a cap in the low 10 dollar range for the intermediate term. With the additional of several painful quarters ahead, as insinuated by the sale of that stock and observed through the update given several weeks ago, we should continue to see downward pressure on the share price targeting the 5.50 to 3.30 dollar range over the next 6 months
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.